Chi-Mei Medical Centre

Tainan 710

0 studies enrolling now · 4 studies all time

What they study most

Cancer of the Prostate, Esophageal Squamous Cell Carcinoma, Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer, Hepatocellular Carcinoma, Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer

Studies at this site

• A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer) — Running, not enrolling
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) — Running, not enrolling